C4orf46: A Potential Drug Target for Various Diseases (G201725)

Target Name: C4orf46

NCBI ID: G201725

C4orf46

C4orf46: A Potential Drug Target for Various Diseases

C4orf46, also known as chromosome 4 open reading frame 46, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its unique genetic mutation has led to a gain of function in the gene, resulting in the production of a hyperactive protein that can cause a range of negative symptoms.

C4orf46 is a gene that is located on chromosome 4, which is one of the 23 pairs of human chromosomes. It encodes for a protein known as C4ORF46, which is a key regulator of the telomere, a protective caps on the ends of chromosomes that shorten as we age. The C4ORF46 protein plays a crucial role in maintaining the stability and integrity of chromosomes, and is considered to be a key regulator of aging and age-related diseases.

The C4ORF46 gene has been identified as a potential drug target or biomarker due to its association with a number of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. One of the main reasons for its potential as a drug target is its role in the regulation of telomere length, which is a well-established risk factor for a range of age-related diseases, including cancer, neurodegenerative disorders, and cardiovascular disease.

C4ORF46 has been shown to play a key role in regulating telomere length, and is thought to influence the stability and integrity of chromosomes. This is important because telomeres are the protective caps on the ends of chromosomes, and shortening of telomeres has been linked to the development of a range of age-related diseases, including cancer, neurodegenerative disorders, and cardiovascular disease.

Studies have shown that C4ORF46 is expressed in a wide range of tissues and cells, including human cancer cells, brain cells, and blood vessels. It has also been shown to be involved in the regulation of a number of cellular processes, including cell division, apoptosis (programmed cell death), and inflammation.

In addition to its role in telomere regulation, C4ORF46 has also been shown to be involved in a number of other cellular processes that are important for the health and function of cells. For example, it has been shown to play a key role in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. C4ORF46 has also been shown to be involved in the regulation of cell migration, which is the process by which cells move from the place where they were born to the place where they are needed to function.

In addition to its role in cellular processes, C4ORF46 has also been shown to be involved in the regulation of gene expression. This is the process by which the instructions in a gene's DNA are used to build the proteins that are responsible for the functions of the cell. Studies have shown that C4ORF46 plays a key role in the regulation of gene expression in a wide range of tissues and cells.

Given its role in a wide range of cellular processes, C4ORF46 is a promising target for drug development. Studies have shown that inhibiting the activity of C4ORF46 has the potential to cause a range of negative symptoms, including the loss of chromosomes, cell death, and the development of cancer. This suggests that C4ORF46 could be an effective drug target for a wide range of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

In conclusion, C4orf46 is a gene that has been identified as a potential drug target or biomarker for a wide range of diseases. Its unique genetic mutation has led to the production of a hyperactive protein that can cause a range of negative symptoms, and its involvement in the regulation of telomere length and other cellular processes makes it an attractive target for drug development. Further research is needed to fully understand the role of C4ORF46 in the development and treatment of various diseases.

Protein Name: Chromosome 4 Open Reading Frame 46

The "C4orf46 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C4orf46 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets